Skip to content
Subscriber Only
Markets

Here's What Wall Street Thinks of Hillary Clinton's Plan to Crack Down on Pharmaceutical Companies

Biotechs, beware.
"There is price gouging this big in pharmaceuticals."

"There is price gouging this big in pharmaceuticals."

Photographer: Andrew Harrer/Bloomberg *** Local Caption *** Hillary Clinton
By

In July 2014, the world's most powerful woman sounded the alarm on biotech valuations.

In testimony before Congress, Federal Reserve Chair Janet Yellen warned that there were some signs of froth in this segment. Her comments sparked a short-lived selloff in the sector.